TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 49 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $442,463 | +482.5% | 140,020 | +21.8% | 0.00% | – |
| Q2 2023 | $75,962 | -17.1% | 114,920 | 0.0% | 0.00% | – |
| Q1 2023 | $91,660 | -82.4% | 114,920 | -50.0% | 0.00% | – |
| Q4 2022 | $519,438 | +248.6% | 229,840 | +196.9% | 0.00% | – |
| Q3 2022 | $149,000 | -48.3% | 77,420 | 0.0% | 0.00% | – |
| Q2 2022 | $288,000 | -91.2% | 77,420 | -84.5% | 0.00% | – |
| Q1 2022 | $3,255,000 | -39.8% | 499,214 | +7.6% | 0.00% | – |
| Q4 2021 | $5,408,000 | -17.5% | 464,169 | +31.8% | 0.00% | – |
| Q3 2021 | $6,558,000 | -2.9% | 352,186 | +10.5% | 0.00% | – |
| Q2 2021 | $6,755,000 | +172.5% | 318,619 | +160.9% | 0.00% | – |
| Q1 2021 | $2,479,000 | -15.2% | 122,141 | +10.9% | 0.00% | – |
| Q4 2020 | $2,922,000 | – | 110,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |